LIVE — 21:28 ET
← All Strategies
WINNING

Glp1 Obesity

Weight loss drug megatrend: $73-87B market, LLY/NVO leaders

3Y
Total Return
+37.6%
3Y
Sharpe Ratio
0.49
3Y
Max Drawdown
-17.7%
3Y
Win Rate
49.5%
3Y
Alpha
-55.1%
3Y
Comp. Score *
0.14
Risk Parameters
Max Allocation5.9%
Stop Loss17.7%
Take Profit5.6%
Max DD Tolerance17.7%
Rebalanceweekly
Execution Guidance
Order TypeLimit
Entry RuleBuy 0.5% below market in uptrend.
TimingSAFE TO BUY. *
ScalingEnter in 3 tranches over 1-2 weeks.
Positions — Vol-Adjusted Sizing
SymbolActionVol Stop LossTake ProfitSizeLinks
PFE BUY 24% 17.8% below entry 5.7% above entry 5.9% TVYH
PLNT BUY 39% 28.8% below entry 9.2% above entry 3.6% TVYH
ISRG BUY 34% 25.6% below entry 8.2% above entry 4.1% TVYH
AMGN BUY 27% 19.8% below entry 6.3% above entry 5.3% TVYH
LLY BUY 38% 28.2% below entry 9.0% above entry 3.7% TVYH
MRK BUY 29% 21.5% below entry 6.8% above entry 4.9% TVYH
ABBV BUY 27% 19.7% below entry 6.3% above entry 5.3% TVYH
VKTX BUY 76% 40.0% below entry 16.9% above entry 2.0% TVYH